First Time Loading...

Pulmonx Corp
NASDAQ:LUNG

Watchlist Manager
Pulmonx Corp Logo
Pulmonx Corp
NASDAQ:LUNG
Watchlist
Price: 9.53 USD 2.69% Market Closed
Updated: May 8, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

164.6m
-7%
Assets
Growth Rates:
1 Year
-18%
3 Years
-36%
5 Years
-
7 Years
-
10 Years
-
54.1m
-9%
Liabilities
Growth Rates:
1 Year
-6%
3 Years
+40%
5 Years
-
7 Years
-
10 Years
-
110.5m
-7%
Equity
Growth Rates:
1 Year
-23%
3 Years
-49%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Pulmonx Corp

164.6m
Assets
54.1m
Liabilities
164.6m
Assets
54.1m
Liabilities
Current Assets 147.9m
Cash & Short-Term Investments 116.1m
Receivables 11.2m
Other Current Assets 20.6m
Non-Current Assets 16.6m
Long-Term Investments 4.3m
PP&E 6.9m
Intangibles 2.3m
Other Non-Current Assets 3.1m
Current Liabilities 21.3m
Accounts Payable 3.1m
Accrued Liabilities 12.5m
Other Current Liabilities 5.7m
Non-Current Liabilities 32.8m
Long-Term Debt 32m
Other Non-Current Liabilities 790k

Balance Sheet
Pulmonx Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4
14
232
142
102
25
Cash
4
7
221
141
97
0
Cash Equivalents
0
6
11
1
5
25
Short-Term Investments
0
15
0
38
39
34
Total Receivables
3
6
5
7
9
13
Accounts Receivables
3
6
4
7
9
12
Other Receivables
0
0
0
0
1
1
Inventory
3
6
11
16
15
17
Other Current Assets
0
1
3
5
4
4
Total Current Assets
11
41
250
208
169
150
PP&E Net
0
8
11
13
11
7
PP&E Gross
0
8
11
13
11
7
Accumulated Depreciation
2
1
2
2
4
5
Intangible Assets
1
1
0
0
0
0
Goodwill
2
2
2
2
2
2
Long-Term Investments
0
0
0
11
6
14
Other Long-Term Assets
0
2
1
1
6
3
Other Assets
2
2
2
2
2
2
Total Assets
15
N/A
54
+257%
264
+393%
235
-11%
194
-18%
178
-8%
Liabilities
Accounts Payable
1
3
2
2
2
1
Accrued Liabilities
6
9
10
14
16
19
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
2
Other Current Liabilities
1
2
1
2
1
1
Total Current Liabilities
8
14
13
18
19
23
Long-Term Debt
34
15
17
17
17
35
Deferred Income Tax
0
0
0
0
0
0
Other Liabilities
0
6
8
7
4
1
Total Liabilities
42
N/A
36
-15%
38
+6%
42
+11%
40
-5%
59
+50%
Equity
Common Stock
141
205
0
0
0
0
Retained Earnings
190
211
243
291
350
411
Additional Paid In Capital
21
22
467
483
503
527
Other Equity
1
1
2
2
2
3
Total Equity
27
N/A
18
N/A
226
+1 156%
193
-15%
154
-20%
118
-23%
Total Liabilities & Equity
15
N/A
54
+257%
264
+393%
235
-11%
194
-18%
178
-8%
Shares Outstanding
Common Shares Outstanding
34
34
36
37
38
39

See Also

Summary
LUNG intrinsic value, competitors valuation, and company profile.
DCF Valuation
LUNG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LUNG stock valuation using valuation multiples.
Wall Street Estimates
LUNG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LUNG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.